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Summary
A fundamental question in cell biology concerns how cells
respond to their environment by polarizing after sensing
directional cues. This requires the differential localization
of protein complexes in cells, and it is important to identify
and understand how these complexes function. Here we
describe a novel ‘‘direction-sensing’’ pathway that links the
integrin effector focal adhesion kinase (FAK [1–7]), the
molecular scaffold protein RACK1 [8–10], and activity of
one of its client proteins, PDE4D5, a cAMP-degrading phos-
phodiesterase. The complex is recruited to nascent adhe-
sions and promotes cell polarity. We identify FAK FERM
domain residues whose mutation impairs RACK1 binding.
When re-expressed in cancer cells in which endogenous
fak is deleted by Cre-lox-mediated recombination, the
RACK1-binding-impaired FAK mutant protein does not
support formation of nascent actin adhesion structures as
cells spread. These cancer cells, like FAK-deficient cells,
cannot undergo directional responses, including wound-
induced polarization or chemotactic invasion into three-
dimensional matrix gels. We show that RACK1 serves as
the molecular bridge linking FAK to the recruitment of
PDE4D5. FAK/RACK1/PDE4D5 is a novel ‘direction-sensing’
complex that acts to recruit specific components of the
cAMP second-messenger system to nascent integrin adhe-
sions and to the leading edge of polarizing cells.
Results and Discussion
FAK and RACK1 Form a Complex in Squamous Cancer
Cells and Colocalize at Nascent Adhesions
We previously showed that focal adhesion kinase (FAK) was
present, and colocalized with RACK1, at nascent protrusive
structures that form as mouse embryonic fibroblasts (MEFs)
spread on extracellular matrix (ECM) [11]. Here we have
derived cells from chemically induced squamous cell carci-
nomas (SCCs) in mice that expressed a floxed form of FAK
under the control of skin-specific Cre recombinase via the
keratin-14 promoter [12].*Correspondence: m.frame@ed.ac.uk
4These authors contributed equally to this workFAK deficiency (FAK-null) in SCCs (as well as in MEFs)
caused severe spreading defects, as judged by a lack of newly
formed protrusive structures after 30 min on fibronectin (FN)
(Figure 1A). FAK and RACK1 colocalized at nascent structures
in SCCs; however, RACK1 was largely cytoplasmic in FAK-null
cells (Figure 1A). We showed that these structures were in
close proximity to the cell-substratum interface by using total
internal reflection fluorescence (TIRF) microscopy (Figure 1B).
The structures did not form properly when FAK-null cells first
contacted the FN-coated substratum (Figure 1B). We also
noted that there were small ‘‘spots’’ of colocalization between
FAK and RACK1 at the periphery of fully adherent cells. These
spots of colocalization were best seen by TIRF microscopy
(Figure 1C). These data indicate that FAK and RACK1 were
also selectively colocalized in motile adherent cells, most likely
at transient nascent contacts close to the cell-substratum
interface, but not at more mature focal adhesions. Thus, the
RACK1-containing structures are early cell-ECM contacts
that can be distinguished from mature focal adhesions by the
presence of RACK1 (similar structures have been described
before [13]). The complete absence of FAK after treatment
with 4-OHT was confirmed (Figure S1, available online), and
we used these cells to re-express mutant FAK proteins to
around 1.5–2 times endogenous FAK levels.
FAK formed a complex with endogenous RACK1 in sus-
pended SCC cells, and this persisted after plating on FN
(Figure 1D). We noted that FAK-Tyr-397 was constitutively
phosphorylated on the integrin-induced autophosphoryation
site, even when placed in suspension, showing that FAK
activity was deregulated, and uncoupled from cell adhesion,
in these cancer cells (Figure 1D, right panel). We showed
that the FAK/RACK1 complex was independent of FAK-Y397
phosphorylation and that, as expected, the FAK/Src complex
was abolished in FAK-Y397F-expressing cells (Figure 1E).
We confirmed specificity of the IP by use of nonimmune IgG
(Figure 1E, right panel). Thus, FAK promotes nascent adhesion
contacts, and FAK binds the scaffold protein RACK1. The two
proteins colocalize at nascent contacts close to the cell-
substratum interface of spreading cells.
FAK-RACK1 Binding Involves the FAK FERM Domain
and Controls RACK1 Localization and Spreading Initiation
A scanning peptide array of full-length FAK was generated as
a library of overlapping 25-mer peptides; each sequence was
displaced 5 amino acids toward the C terminus, as in 1–25,
6–30 etc. This immobilized peptide array was probed with
either purified GST or a purified GST-RACK1 fusion protein
and used, in conjunction with alanine scanning mutagenesis,
for identifying amino acids whose mutation might interfere
with the FAK-RACK1 interaction, thus guiding the generation
of a putative effector mutant (described in detail in the legend
to Figure S2A). The potential binding regions predicted by this
approach were in the FAK FERM domain, identifying RACK1 as
a novel FERM-interacting protein.
We made two putative interfering mutations in full-length
FAK and expressed the mutants in FAK-deficient SCCs.
One of these, FAK-E139A,D140A, greatly impaired binding
of FAK to RACK1 (Figure 2A, left panel). The other mutant,
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Figure 1. FAK and RACK1 Form a Complex in Squamous Cancer Cells and Colocalize at Nascent Adhesions
(A) FAK-null or FAK-wt SCCs and MEFs were suspended in PBS for 1 hr and then plated on FN (10 mg/ml) for 30 min. Cells were fixed and stained with anti-
RACK1 (red) and anti-FAK (green) and visualized with confocal miocroscopy. Merged images are shown (right panels). Solid arrows indicate colocalization ,
and broken arrows indicate cytoplasmic RACK1. SCC cells plated on FN were stained with (B) anti-RACK1 or (C) anti-RACK1 (red) and anti-FAK (green),
then imaged via TIRF. Merged and zoomed images are shown. A solid arrow shows mature focal adhesion, and a broken arrow indicates small nascent
adhesion. (D) FAK-null SCCs re-expressing FAK-wt were suspended and then plated on FN. RACK1 was immunoprecipitated (IP), and immunoblotting
was carried out with anti-FAK, anti-RACK1, and anti-FAK Y397 as probes. (E) RACK1 was immunoprecipitated from FAK-wt or FAK-Y397F cells. Immuno-
blotting was carried out with anti-FAK and anti-RACK1 as probes. FAK was also immunoprecipitated from these cells, and immunoblotting was carried out
with anti-FAK and anti-Src as probes. Control IP is shown for non-immune IgG (right panel), with anti-FAK and anti-RACK1 as probes. Scale bars represent
20 mm.
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1087FAK-E237A,E238A, did not (sometimes such false positives
arise in binding arrays and inhibition of binding is not repli-
cated in the context of the full-length protein in cells). FAK-
E139A,D140A did not affect the association of FAK with
Arp3, which bound to a different region of the FAK-FERM
domain (Figure S2B [11]). Further characterization of this
RACK1-binding-deficient FAK mutant showed that it was
tyrosine phosphorylated at Y397 and was associated with
phospho-Src and paxillin (Figures S2C and S2D). Although
RACK1 binds Src [14], we did not find that RACK1 associationwith Src was altered in cells expressing the FAK-E139,D140A
mutant (Figure S2E).
Disruption of the FAK/RACK1 complex in adherent cells
impaired the ability of RACK1 to locate to protrusive structures
at cell edges, and the cells were poorly spread. They appeared
either round or triangular, and RACK1 was cytoplasmic (Fig-
ure 2B and Figure 2C). In FAK-wt- and FAK-E237A:E238A-
expressing cells, RACK1 was concentrated in the vicinity of
membrane protrusions, and there were nonstaining regions
between the protrusions and the nucleus, as shown by digital
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Figure 2. FAK-RACK1 Binding Involves the FAK
FERM Domain and Controls RACK1 Localization
and Spreading Initiation
(A) RACK1 was immunoprecipitated from FAK-
wt, FAK-E237A,E238A, or FAK-E139A,D140A
cells. Immunoblotting was then carried out with
anti-FAK and anti-RACK1 as probes.
(B) Adherent SCC cells were fixed and stained
with anti-RACK1 (green) and DAPI (blue) (left
panels) or with anti-RACK1 (red) and anti-FAK
(green) (right panels). Solid arrows indicate
peripheral RACK1, and broken arrows indicate
cytoplasm (left panels) or cytoplasmic RACK1
(right panels).
(C) FAK-wt, FAK-E237A,E238A, or FAK-E139A,
D140A cells were suspended, plated on FN, and
then fixed and stained with TRITC phalloidin
(red). Solid arrows represent spreading cells,
and broken arrows indicate rounded cells.
(D) Cells were suspended, plated on FN, fixed
and stained with anti-RACK1 (green) and DAPI
(blue), and imaged with DIC. Solid arrows indi-
cate the formation of protrusive structures, and
broken arrows indicate a lack of such structures.
Scale bars represent 20 mm.
(E) FAK-wt (left panels) or FAK-E139A,D140A
(right panels) cells expressing Ds-Red actin and
RACK1-GFP were plated on FN and imaged in
real time every minute for 20 min (Movie S1 and
Movie S2). Still series from zoomed images are
shown. In the left series, a solid arrow shows
protrusion in which RACK1-GFP moves back to
the cytoplasm while actin remains, and a broken
arrow shows a new actin-based adhesion that
forms later and at which RACK1-GFP is present.
In the right series, an arrow shows dynamic
peripheral actin ruffles that are devoid of
RACK1-GFP and do not stabilize.
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1088image contrast (DIC) (Figure 2B, solid arrows). RACK1 did not
colocate with FAK at the periphery of FAK-E139A,D140A-
expressing cells, and these cells had less obvious direction-
ality (cells were triangular in shape and had smooth edges;
Figure 2B, lower right panel). Costaining of FAK with paxillin
at the cell periphery is shown in Figure S2D, right panel. Actin
staining in cells expressing FAK-E139A,D140A revealed that
these were poorly spread at 30 and 60 min after plating on
FN, and assembly of protrusive actin structures was reduced
(Figure 2C), reminiscent of FAK-deficient cells. Quantification
of cells with actin protrusions is shown (Figure S2F). In spread-
ing cells, the concentration of cellular RACK1 in the vicinity
of protrusions was not seen in cells expressing the FAK-
E139A,D140A mutant, which remained rounded (Figure 2D).
We next generated time-lapse movies of cells expressing
Ds-red actin and RACK1-GFP as they contacted FN-coated
substrata (Movie S1 and Movie S2). Still images from these
are shown (Figure 2E). In the case of FAK-wt-expressing cells,
dynamic actin-based protrusive ‘‘blebbing’’ structures were
evident, and RACK1 entered and left these over time. In stark
contrast, although there was actin ruffling activity at the edgesof cells expressing the FAK-E139A,
D140A mutant, RACK1-GFP did not
‘‘visit’’ peripheral actin structures, and
protrusions did not form or persist
(Figure 2E). These data are consistent
with RACK1’s ‘‘visiting’’ peripheral
actin structures transiently in a FAK-dependent manner as they assemble and suggest that the
FAK/RACK1 complex delivers a signal that promotes stabiliza-
tion of dynamic ‘‘first-contact’’ adhesions.
FAK-RACK1 Binding Is Needed for Wound-Induced Cell
Polarization and Chemotactic Cancer Cell Invasion
We next examined the ability of FAK-E139A,D140A cells to
polarize toward a wound created in a confluent monolayer by
using an assay that visualized the orientation of Golgi relative
to the nucleus [15]. FAK-deficient (FAK-null) cells and cells re-
expressing FAK-E139A:D140A were unable to polarize toward
the wound, demonstrating either an inability to sense the space
created by the wound or an inability to turn toward it (Figure 3A).
In parental SCC cells and FAK-null cells re-expressing wild-
type FAK (FAK-wt), endogenous RACK1 localized along the
leading edge of cells at the wound front (Figure S3A, solid
arrows). In contrast, RACK1 did not efficiently localize to the
polarizing edges of FAK-null or FAK-E139A,D140A cells, and
the cells were disorganized (Figure S3A, broken arrows).
Next, cells were seeded onto transwell filters and allowed to
invade through Matrigel toward a chemotactic stimulus (in this
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Figure 3. FAK-RACK1 Binding Is Needed for
Wound-Induced Cell Polarization and Chemo-
tactic Cancer Cell Invasion
(A) FAK-wt, FAK null, and FAK-E139A,D140A
cells were plated on FN for 2 hr, wounded, and
after 1.5 hr fixed and stained for the Golgi marker
anti-GM130 (green), TRITC phalloidin (red), and
DAPI (blue). Solid arrows show cells in which
the Golgi is orientated toward the wound, and
broken arrows indicate cells in which it is orien-
tated away from the wound. Scale bars represent
20 mm. The percentage of each cell type with the
Golgi orientated to the wound was calculated
from a count of 100 cells in three experiments.
Standard errors of means obtained in three indi-
vidual experiments are shown.
(B) FAK-wt, FAK null, and FAK-E139A,D140A
cells were seeded on transwell filters and
allowed to invade Matrigel toward a serum
gradient. After 72 hr cells were labeled with cal-
cein AM and visualized by confocal microscopy
in the Matrigel at 15 mm intervals. Quantification
is shown in Figure S3B.
(C) FAK-wt and FAK-E139A,D140A cells were
plated overnight, and random migration was
then studied with an Olympus Scan-R timelapse
imaging system. ImageJ was used for tracking
the migration of 60 cells, and the pattern of
migration (left panel) and the speed of migration
were calculated (right panel). Cells that have
changed direction are shown (arrows). Standard
errors of means obtained in three individual
experiments are shown.
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1089case, 10% serum). After 72 hr, cells were labeled with calcein
AM dye and visualized in the Matrigel at 15 mm intervals by
confocal sectioning (Figure 3B), and the percentage of cells
invading 90 mm into the 3D-gels was quantified (Figure S3B).
FAK-deficient cells did not invade at all, and FAK-E139A,
D140A-expressing cells displayed impaired chemotactic inva-
sion relative to that of FAK-wt-expressing control cells (Fig-
ure 3B and Figure S3B). However, although slow, 2D planar
migration of isolated tracked cells was unaffected by disrup-
tion of the FAK/RACK1 complex, and there was no difference
in the ability of single cells to move or execute random turning
manoeuvers in 2D culture (Figure 3C). These data imply that
the FAK-E139A,D140A-expressing cells are impaired at
sensing, and responding to, directional cues such as wounds
or chemotactic stimuli, rather than at moving or turning, per se.
The incomplete inhibition of invasion of SCC cells expressing
FAK-E139A,D140A, and their delayed ability to repair a mono-
layer wound (Figure S3C), could be due to the fact that some
cells are in the correct orientation for forward migration by
chance and do not have to polarize, i.e., turn toward the serum
gradient, to move into the Matrigel or the wound.FAK and RACK1 Are in Complex
with PDE4D5, which Is Required
for Nascent Adhesions
and Cell Polarization
In search of the mechanism by which
the FAK/RACK1 complex mediates
nascent adhesion assembly and direc-
tional responses, we considered known
binding partners of RACK1. Cyclic AMP
(cAMP) has been shown to affect cell
shape and migration, and we knew thatthe cAMP-specific phosphodiesterase PDE4D5 interacts
with RACK1 via its isoform-specific N-terminal region [16–18].
To examine whether PDE4D5 was associated with FAK in
a complex that also contained RACK1, we immunoprecipi-
tated FAK from FAK-wt- and FAK-E139A,D140A-expressing
SCC cells and probed for the presence of both PDE4D5 and
RACK1. Endogenous PDE4D5 associated with FAK in FAK-
wt cells, but this association was reduced in cells expressing
FAK-E139A,D140A (Figure 4A, quantified in Figure S4A). These
data show that FAK is present in a larger complex together
with RACK1 and PDE4D5 and that RACK1 probably acts as
a molecular ‘‘bridge’’ linking FAK to PDE4D5. Consistent with
this, the RACK1/PDE4D5 complex was independent of FAK’s
binding to RACK1 (Figure 4A, right panel). Importantly, there
was a pool of endogenous PDE4D5 that colocalized with
RACK1 at nascent protrusions at the substratum interface as
cells were plated on FN, as shown by TIRF microscopy
(Figure 4B). We also found colocalization of RACK1 and
PDE4D5 in cells at the polarized edge of wounded monolayers
(merged images in Figure S4B), and this was perturbed in
FAK-E139A,D140A-expressing cells where neither RACK1
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Figure 4. FAK and RACK1 Are in Complex with
PDE4D5 and Colocalize at Nascent Adhesions
(A) FAK-wt and FAK-E139A,D140A cells were
suspended, then plated on FN. Cells were immu-
noprecipitated with either anti-FAK agarose
or anti-RACK1, and then immunoblotting was
carried out with anti-PDE4D5, anti-RACK1, and
anti-FAK as probes. Lane 3 shows a control IgG
precipitation of FAK null cells.
(B) FAK-wt and FAK-E139A,D140A cells were
plated on FN and then stained with anti-
PDE4D5 (green) and anti-RACK (red). Adhesions
at the cell substratum interface were detected
with TIRF. A merged image is shown (colocalized
RACK1 and PDE4D5 are yellow; solid arrow).
Scale bars represent 20 mm.
(C) SCC cells were pre-incubated for 2 hr with
10 mM of peptide 765 (middle panel) or peptide
766 (right panel), which disrupted binding
between PDE4D5 and RACK and between
PDE4D5 and b-arrestin, respectively. Cells were
plated on FN, then fixed and stained with anti-
RACK1 antibody (red) and imaged by DIC. Solid
arrows indicate the formation of protrusive struc-
tures, and broken arrows indicate rounded cells.
(D) Cells were suspended with 10 mM rolipram for
1 hr, plated on FN for 30 min in the presence of
rolipram, and then fixed and stained with TRITC
phalloidin and DAPI. Zoomed images and quanti-
tation are also shown. Scale bars represent
20 mm. Cells with smooth edges rather than
protrusive nascent adhesions are quantified.
(E) Polarization assays were carried out on SCC
cells that were plated and wounded in the pres-
ence of peptide 765, peptide 766, DMSO, or roli-
pram. Cells were fixed and stained for the Golgi
marker anti-GM130, TRITC phalloidin, and DAPI,
and the percentage of cells with the Golgi orien-
tated to the wound is shown. Standard errors of
means obtained in three individual experiments
are shown.
(F) Polarization assays were also carried out in
the presence of 8-CPT-2OMe cAMP (10 mM) and
8-Brm-cAMP (10 mM). The percentage of cells
with the Golgi orientated to the wound is shown.
Standard errors of means obtained in three indi-
vidual experiments are shown.
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1090nor PDE4D5 efficiently localized to the polarizing edges
(Figure S4B).
Next, we used a previously characterized peptide that, when
stearoylated to make it membrane permeable, specifically
disrupts the RACK1-PDE4D5 complex (peptide 765) in cells
and compared its action with a peptide that specifically
disrupts a PDE4D5 complex with another molecular scaffold
protein, namely b-arrestin (peptide 766) [16, 17]). We examined
cell spreading by DIC imaging of SCC cells in either the
absence or presence of each of these stearoylated peptides
(Figure 4D). There was only a striking loss of peripheral protru-
sions and spread morphology in cells incubated with the
PDE4D5-RACK1-disrupting peptide 765 (quantified in Fig-
ure S4C). Importantly, we confirmed that, when compared to
control peptide 766 (Figure S4D), peptide 765 suppressed
binding to PDE4D5.
To further test the hypothesis that PDE4D5 has a role in medi-
ating the effects we observed here, we made use of the PDE4-
specific inhibitor rolipram (reviewed in [19]). Rolipram impaired
the formation of protrusive nascent adhesions; the edges of
treated cells had smooth edges with regions of dense corticalactin (the latter might have arisen from inhibition of PDE4D iso-
forms other than PDE4D5;Figure 4D). Furthermore, rolipram,
and the RACK1/PDE4D5 disruptor peptide (peptide 765),
inhibited polarization (Figure 4E), and rolipram inhibited
chemotactic invasion (not shown). We also artificially elevated
cAMP by use of the analogs 8-Brm-cAMP and 8-CPT-2-OMe-
cAMP and found that these mimicked inhibition of polarization
induced by RACK1-binding-impaired FAK mutant FAK-
E139A,D140A (Figure 4F). Finally, we expressed a dominant-
negative form of PDE4D5 generated by the mutation of
Asp556 to alanine (described previously in [20]). Expression
of PDE4D5-D556A was possible for short times and reduced
formation of nascent protrusive adhesions when cells were
plated on FN (Figure S4E, broken arrows). We confirmed that
the dominant-negative PDE4D5 did not disrupt the RACK1/
FAK complex (Figure S4E). Taken together, our data provide
compelling evidence that the catalytic activity of PDE4D5
is required for generating and maintaining the spread pheno-
type and for stimulus-induced polarization. This is consistent
with FAK/RACK1-recruited PDE4D5’s functioning to keep
cAMP levels low in a spatially constrained manner at nascent
A Nascent Adhesion Complex Controls Polarity
1091adhesions as they form and at the leading edges of polarizing
cells. We were not successful in knocking down RACK1 protein
efficiently in the cancer cells used here, and we did not knock
down PDE4D family PDEs because we reasoned that this would
have been unlikely to phenocopy effects of the more subtle
approaches we took to disrupt only one complex, namely the
FAK/RACK1/PDE4D5 direction-sensing polarity complex.
Our data show that when the FAK-RACK1 complex is per-
turbed, neither RACK1 nor PDE4D5 can localize to nascent
adhesion structures or to the leading edge of polarizing cells.
The FAK/RACK1 complex serves to recruit PDE4D5 and
promote spreading and polarization; RACK1 acts as an inter-
mediary scaffold. The consequences of loss of the FAK/
RACK1 complex mimic FAK deficiency and might contribute
to FAK’s role in promoting the invasive cancer cell phenotype
that we have demonstrated previously in squamous cell and
breast cancers in vivo [12, 21].
The mechanisms underlying assembly and distribution of
signaling complexes as cells first contact the ECM remain
unclear. Previous studies have identified protein complexes
that regulate polarization in a number of contexts. For exam-
ple, integrin-induced activation of Cdc42 controls the ability
of astrocytes to polarize in response to a wound made in
a confluent cell monolayer by leading to the activation and
recruitment of the well-studied mPar6/PKCz polarity complex
[15, 22]. However, it is likely that other polarization-deter-
mining protein complexes, perhaps acting as part of a network,
exist and that some of these modulate peripheral actin struc-
tures across cells to promote directionality.
Although cancer cells frequently lose apical-basolateral
polarity, it is likely that polarization and directional migration
toward chemotactic stimuli, such as cytokines or chemokines,
play a role in metastatic spread during cancer invasion. Yet we
do not understand how cancer cells turn toward polarization
stimuli, and little is known about protein complexes specifi-
cally involved in direction sensing. We have found that FAK
is needed for wound-induced polarization of SCC cells and
chemotactic invasion through 3D matrix gels. In pursuing the
mechanisms by which FAK functions, we have found that the
complex between FAK and RACK1, and between RACK1
and its client protein PDE4D5, are required for SCC cancer
cells to sense direction and respond. This complex is permis-
sive, and essential, for assembly of actin-based protrusive
structures at cell edges as cells spread or polarize in response
to directional cues. Our time-lapse movies suggest that the
FAK-RACK1 complex acts to stabilize a subset of actin adhe-
sion structures as they form; in turn, this might specify cell
shape (leading and trailing edges) and so directionality. We
think we have uncovered one of the earliest spatially regulated
signaling complexes that regulates nascent actin-based adhe-
sion structures, the spread phenotype, and direction sensing
in response to environmental cues.
Experimental Procedures
Cells
pWZL-FAK constructs were used for generating FAK-deficient (FAK-null)
MEFs (control cells; kind gift from D. Ilic, StemLifeLine, CA), FAK-wt, FAK-
Y397F, FAK-KD, and FAK-Y4F-Y9F reconstituted FAK-null SCC cells as
pools with amaxa nucleofection kit v, program P20, and cells were main-
tained in 0.4 mg/ml hygromycin B.
In Vitro Complex Analysis
GST-RACK1 recombinant protein coupled to glutathione agarose beads
(0.5 mg) was preincubated with either peptide 765 or 766 for 1 hr in PBS at4C prior to the addition of recombinant PDE4D5 (0.5 mg). The samples
were incubated at 4C for a further 30 min and washed three times in cold
PBS, and SDS sample buffer was added. Samples were analyzed by immu-
noblotting with anti-PDE4D5 and anti-RACK1.
Immunocytochemistry and Cell Polarization Assays
Immunocytochemistry was performed as described in the Supplemental
Information. For the analysis of cell spreading, cells were trypsinized,
washed, and resuspended in PBS, then incubated with rotation at 4C for
1 hr. Cells were then plated on FN-coated (0.01 mg/ml human FN) coverslips
for the indicated times in serum-free medium. Cell-permeable peptides
were added to the cells for 2 hr prior to rotation, and cAMP compounds
were added prior to rotation and again upon plating. For polarization
assays, cells were plated on FN at a density of 3 3 106 cells per well on
a 12-well dish for 2 hr. Cells were then wounded with a pipette tip, washed
twice in PBS, maintained in complete media for 1.5 hr, and then fixed. Cell-
permeable peptides or cAMP compounds were added to the cells upon
plating and again after wounding.
Invasion Assays
Invasion was assessed with an in vitro inverse invasion assay. In brief, 100 ml
of growth-factor-reduced Matrigel was diluted 1:1 in cold PBS and allowed
to set at 37C for 1 hr in polycarbonate transwells. Cells (1 3 104) were
seeded onto the underside of the transwell filter and allowed to adhere for
4 hr. Transwells were washed and placed in serum-free medium. Normal
growth medium containing 10% serum was added above the Matrigel,
and cells were allowed to invade for 72 hr. Cells were then stained with
5 mM calcein-AM for 1 hr at room temperature, and horizontal z sections
through the Matrigel were examined at 15 mm intervals with an Olympus
FV1000 confocal microscope. The amount of dye (positive pixels) was
calculated for each z section with ImageJ software and expressed as
a percentage of the section that represents the base of the transwell filter.
Random-Cell-Migration and Wound-Polarization Assay
For the random-migration and wound-polarization assays, 0.5 3 104 and
1 3 106 cells, respectively, were plated on a 6-well tissue culture dish in
the presence of serum-containing media and allowed to adhere overnight.
Plates were then washed with fresh media and placed in a microscope
humidity chamber that was maintained at 37C and supplemented with
CO2. Cell migration or wound closure was monitored for 15 hr with an
Olympus scan R microscope, and sequential images were captured at
15 min intervals. Analysis was performed with imageJ software.
Supplemental Information
Supplemental Information includes three figures and two movies and can be
found with this article online at doi:10.1016/j.cub.2010.04.042.
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